The U.S. Food and Drug Administration (FDA) has recently cleared the Corpath 200 system, the world's fist robotic-assisted system for minimally invasive treatment of coronary artery disease. Philips Healthcare announced on August 22, 2012, that they will be the exclusive distributor of Corindus' interventional cardiology system in the United States...
via Medical News Today
via Medical News Today
No comments:
Post a Comment